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Abstract
To further understand the epidemiology of Streptococcus pyogenes or group A streptococcus (GAS) infections in Tunisia, phenotypic and
genomic markers of GAS isolates, including antibiotic susceptibility, biotypes, T and emm types and toxin gene proﬁles, have been char-
acterized. A total of 103 isolates, collected between 2000 and 2006, were investigated; 47 were recovered from invasive infections, and
56 from non-invasive infections. Rates of tesistance to tetracycline, erythromycin, clindamycin and rifampin were 70.8%, 4.8%, 4.8% and
0.9%, respectively. High levels of resistance to streptomycin and kanamycin were observed in 1.9% and 4.8% of isolates, respectively.
Biotype 3 was most common. Twenty different T patterns were observed, with a predominance of T3/13/B3264, and 38 different emm
types. In both invasive and non-invasive isolates, emm118 (9.7%), emm42 (8.7%), emm1 (7.8%), st432 (6.8%), emm28 (5.8%) and emm76
(5.8%) were the most prevalent types; emm1, emm76 and emm18 were mainly observed among invasive infections, whereas emm118
(12.5%), emm42 (10.7%) and emm28 (8.9%) were predominant among non-invasive infections. The speB gene was detected in all isolates,
but there were variable frequencies of speA, speC and ssa (20.3%, 32% and 25.2% respectively). Signiﬁcant associations of emm1, emm18
and emm3 with speA and of emm4 and st432 with ssa were found. This ﬁrst report from Tunisia revealed a unique emm distribution of
GAS that differs from those of other regions. This information on the distribution of such emm types will be useful for the development
of an appropriate vaccine in a country where the incidence of rheumatic fever remains high.
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Introduction
Streptococcus pyogenes—group A streptococcus (GAS)—is a
human pathogen that causes a wide spectrum of diseases,
ranging from relatively benign infections, such as pharyngitis
and pyoderma, to severe invasive diseases. It can also lead to
serious non-suppurative sequelae, including acute rheumatic
fever and acute glomerulonephritis [1]. In the late 1980s,
severe invasive GAS infections re-emerged, and since then the
increasing incidence and severity of these infections have been
the focus of attention [2]. This dramatic rise may be due to
changes in speciﬁc virulence factors, and strain characteriza-
tion has therefore assumed great importance [3,4]. Among the
numerous virulence factors produced by GAS, the M protein,
encoded by the emm gene, is considered to be a major factor.
Sequence analysis of emm has become an important surveil-
lance tool for investigating the dynamics of GAS infections, and
approximately 170 emm types and 750 emm subtypes have
been documented [5]. Furthermore, GAS produces a range of
streptococcal pyrogenic exotoxins, which are important in the
pathogenesis of severe GAS infections, where they act as su-
perantigenic toxins (SAgs) [6]. The gene distribution of SAgs
has been used as an additional epidemiological tool for the
exploration of genomic heterogeneity and possible correla-
tions between toxin gene content and disease type [3].
Studies of GAS distribution have been performed in several
countries, but, to our knowledge, no study on GAS epidemiol-
ogy and SAg distribution among invasive and non-invasive GAS
isolates has, to date, been conducted in Tunisia.
To further understand GAS infections, we analysed the
epidemiological markers of GAS isolates obtained at the
university hospital of Tunis during a 7-year period, including
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susceptibility to 13 antibiotics, biotypes, T and emm types,
and toxin gene proﬁles.
Materials and Methods
Isolates
Of the 160 non-duplicated GAS isolates obtained at the labo-
ratory of Microbiology of Charles Nicolle University Hospital
of Tunis between January 2000 and December 2006, 103
were investigated. The specimens were obtained from both
inpatients and outpatients, aged from 2 to 93 years.
Invasive infection was deﬁned as the isolation of GAS from
sites that are usually sterile, including blood, cerebrospinal,
peritoneal, pleural and joint ﬂuids, and deep tissue abscesses,
or from a superﬁcial site in association with streptococcal
toxic shock syndrome (STSS) or necrotizing fasciitis (NF).
Non-invasive isolates were those that were collected from
sites that are usually non-sterile (skin, throat, ear, genital
tract and others) [7].
All GAS isolates were grown on blood agar plates in 5%
CO2 at 37C overnight. They were identiﬁed by their colony
morphology, b-haemolysis, absence of catalase, group A
agglutination (bioMe´rieux, Marcy l’Etoile, France), and pres-
ence of pyrrolidonyl arylamidase as tested by the disk
method (Oxoid, Dardilly, France).
Antimicrobial susceptibility testing
Antimicrobial susceptibility was investigated using the disk
diffusion method, according to the guidelines of the Antibio-
gram Committee of the French Society for Microbiology
(http://www.sfm.asso.fr), using commercialized disks (Bio-
Rad, Marnes-la-Coquette, France). Thirteen antimicrobial
agents were tested: penicillin G (10 UI), amoxycillin (25 lg),
cefotaxime (15 lg), vancomycin (30 lg), teicoplanin
(30 lg), rifampin (30 lg), tetracycline (30 UI), streptomycin
(500 lg), kanamycin (1000 lg), gentamicin (500 lg), erythro-
mycin (15 UI), clindamycin (2 UI) and pristinamycin (15 lg).
Resistance to bacitracin was determined by absence of an
inhibition zone around the disk of bacitracin (0.04 IU).
The phenotypes of macrolide–lincosamide–streptogram-
in B (MLSB) resistance (constitutive MLSB (cMLSB), inducible
MLSB and M phenotype) were identiﬁed using the double-
disk diffusion method with erythromycin and clindamycin
disks [8].
Biotyping
Biotypes were determined by the presence or not of b-glucu-
ronidase and the results of carbohydrate fermentation when
tested on the rapid ID32 STREP strips (bioMe´rieux) [9].
T typing
The T type was determined by slide agglutination of trypsin-
digested suspensions of washed bacterial cells in the pres-
ence of type-speciﬁc antisera (Sevapharma, Prague, Czech
Republic) [10].
emm sequence typing
The emm types were determined by sequencing the variable
5¢-end of the emm gene after ampliﬁcation by PCR accord-
ing to the Centers for Disease Control and Prevention
recommendations (http://www.cdc.gov/ncidod/biotech/strep/
doc.htm).
A sequence was deemed to belong to a speciﬁc emm
gene when, over the ﬁrst 160 bases of the sequence, it had
95% or greater identity with that of the reference emm
gene.
Detection of speA, speB, speC and ssa
The genes encoding pyrogenic exotoxins type A (speA),
type B (speB) and type C (speC) and superantigen A (ssa)
were detected by a multiplex PCR with primer pairs speciﬁc
for each gene, as described previously [3].
Statistical analysis
Chi-square or Fisher’s exact test was used for statistical anal-
ysis. A p-value £0.05 was considered to be signiﬁcant.
Results
Isolates
A total of 103 GAS isolates was included in this study; 47
(45.6%) were from patients with invasive infections, and 56
(54.4%) from non-invasive cases. Skin and soft tissue infec-
tions related to deep surgical wound infections (n = 9), cellu-
litis (n = 4), erysipelas (n = 3) and NF (n = 2) were the most
frequent clinical manifestations of invasive cases (18 of 47;
38.3%). The rest included bacteraemia without speciﬁc focus
(n = 11), lymphadenitis (n = 5), arthritis (n = 5), osteitis
(n = 4), and meningitis, endocarditis, peritonitis and endome-
tritis (one case each). STSS was observed in one case of bac-
teraemia without speciﬁc focus and one case of cellulitis.
The clinical presentations of the 56 non-invasive isolates
were: tonsillitis (n = 34), impetigo and other superﬁcial skin
infections (n = 20), vaginitis (n = 1), and urinary tract infec-
tion (n = 1).
Biotypes
Among the 103 isolates, ﬁve different biotypes were identi-
ﬁed. Biotype 3 was the most common (60% of invasive
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isolates and 55% of non-invasive isolates), followed by bio-
type 1 (23% of invasive isolates and 23% of non-invasive iso-
lates) and biotype 5 (13% of invasive isolates and 13% of
non-invasive isolates) (Table 1).
Antimicrobial susceptibility
All isolates were susceptible to penicillin G, amoxycillin, cef-
otaxime, pristinamycin, vancomycin and teicoplanin, and
showed low levels of resistance to gentamicin.
The highest proportion of resistance was found for tetra-
cycline (70.8%). Levels of resistance to erythromycin, clinda-
mycin, rifampin and bacitracin were 4.8%, 4.8%, 0.9% and
2.9%, respectively. High levels of resistance to streptomycin
and kanamycin were seen in 1.9% and 4.8% of isolates,
respectively. All erythromycin-resistant isolates expressed
the cMLSB phenotype.
Distribution of T types
Of the 103 GAS isolates, 61 were typeable (59%). Twenty
different T patterns were observed; T3/13/B3264, T1, T4
and T11 were the most frequent, and accounted for 59%
of all T-typeable isolates (Table 2 and Fig. 1a). Common
T patterns of invasive isolates were T3/13/B3264 (19.2%)
and T1 (14.9%). Common T patterns of non-invasive
TABLE 1. Biotypes of 103 Streptococcus pyogenes isolates
from invasive and non-invasive infections
Characteristic
Biotypes
1 2 3 5 6
Acidiﬁcation of:
Mannitol ) ) ) ) +
Cyclodextrin + + ) ) )
Glycogen + + ) ) )
Pullulan + + + + +
Methyl-b-D-glucopyranoside + + + + +
Production of b-glucuronidase ) + ) + )
Total number of strains (%) 24 (23) 6 (6) 59 (57) 13 (13) 1 (1)
Invasive strains, N = 47 (%) 11 (23) 2 (4) 28 (60) 6 (13) 0
Non-invasive strains, N = 56 (%) 13 (23) 4 (7) 31 (55) 7 (13) 1 (2)
+, positive result; ), negative result.
TABLE 2. Type distribution of Streptococcus pyogenes strains in Tunisia and correlation with genes of superantigens
emm type
Number of strains
(invasive/non-invasive) Biotype T types
Genes of toxin or superantigen
speA speB speC ssa
emm118 10 (3/7) 3 T3/5, T3/27/44 or NT ) + ) )
emm42 9 (3/6) 1 T3/13/B3264 or NT ) + ) )
emm1 8 (7/1) 1 T1 + + +/) )
st432 7 (4/3) 3 T8/14/25, T9/14/B3264 or NT ) + +/) +
emm28 6 (1/5) 1 or 3 T11/28, T3/13/B3264 or NT ) + +/) )
emm76 6 (6/0) 3 T12 or NT ) + ) +/)
emm4 4 (4/0) 1 T4 or NT + + +/) +
emm6 4 (1/3) 3 T6 ) + + )
emm18 4 (4/0) 3 T3/13/B3264 + + ) )
emm3 3 (1/2) 3 T3/13/B3264 or NT + + +/) +/)
emm11 3 (1/2) 5 T11 +/) + +/) +
emm12 3 (0/3) 3 T12 or T11/12/44 ) + +/) )
st3757 3 (2/1) 3 NT ) + +/) )
emm22 2 (0/2) 1 T3/13/B3264 or T12/13/B3264 ) + ) +
emm60 2 (1/1) 5 T4 or T4/8 ) + ) )
emm63 2 (0/2) 5 T4 or NT ) + ) +
emm67 2 (2/0) 1 T3/13/B3264 + + + )
emm77 2 (0/2) 2 T3/9/13 or NT ) + + )
emm81 2 (1/1) 3 T6/23 or NT ) + +/) )
emm106 2 (1/1) 5 T3/9/13 or NT ) + ) )
emm2 1 (0/1) 2 T2/8/25/Imp19 ) + + )
emm17 1 (1/0) 3 NT ) + + )
emm26 1 (0/1) 3 T3/13/B3264 + + ) +
emm33 1 (1/0) 3 NT ) + + +
emm43 1 (0/1) 3 NT ) + ) +
emm48 1 (0/1) 2 T4/T28 ) + + )
emm59 1 (0/1) 6 T11 ) + ) )
emm66 1 (0/1) 3 T4 ) + ) )
emm75 1 (1/0) 2 T2/8/25/Imp19 ) + + )
emm85 1 (1/0) 5 T3/13/B3264 ) + ) )
emm87 1 (1/0) 3 NT ) + ) +
emm89 1 (1/0) 5 T13 or NT ) + ) )
emm92 1 (0/1) 3 NT ) + ) )
emm94 1 (0/1) 3 T3/13/B3264 ) + ) )
emm102 1 (1/0) 5 T11 ) + + )
emm104 1 (1/0) 2 B3264 ) + ) )
st1389 1 (0/1) 5 NT ) + ) )
st2861UK 1 (0/1) 3 NT ) + + )
NT, non-typeable; ), negative result; +, positive result; +/), toxin or superantigen gene detected in some of the strains.
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isolates were T3/13/B3264 (16.1%), T4 (8.9%) and T11
(7.1%).
Distribution of emm types
The 103 isolates displayed 38 distinct emm types. The six
predominant emm types were emm118 (9.7%), emm42
(8.7%), emm1 (7.8%), st432 (6.8%), emm28 (5.8%) and
emm76 (5.8%) (Fig. 1b). They accounted for 44.6% of GAS
isolates. A total of 18 different emm types, accounting for
47.6% of the isolates, are included in the 26-valent vaccine
based on M serotypes [11].
The emm118 (12.5%), emm42 (10.7%) and emm28 (8.9%)
types predominated among the non-invasive cases; emm1
(14.9%) (p £0.02), emm76 (12.8%) (p £0.007) and emm18
(8.5%) (p £0.04) were signiﬁcantly associated with invasive
infections (Fig. 1b and Table 2).
Three of four GAS isolates causing arthritis were st432.
The two isolates from patients with STSS were emm76, and
the two from patients with NF were emm85 and emm67.
Erythromycin resistance was restricted to three emm
types: emm28 (n = 2/6), emm11 (n = 2/3) and emm12 (n = 1/
3).
Distribution of SAgs and toxin proﬁles
All GAS isolates expressed the chromosomal speB gene. The
speA, speC and ssa genes, which have been associated with
prophage elements, were present in 20.3%, 32% and 25.2%
of isolates, respectively. A signiﬁcant difference was observed
only for speA, which was more frequent in isolates from
invasive cases (31.8%, p £0.007). The speA gene was found in
33% of isolates from blood and 15% of those from the phar-
ynx, whereas speC was found in 16% of isolates from blood
and 44% of those from the pharynx.
The biotype, T type, emm type and SAg proﬁles demon-
strated signiﬁcant associations between the emm1, emm18
and emm3 types and speA, and between the st432 and emm4
types and ssa (p £0.05) (Table 2).
Furthermore, a signiﬁcant association was observed in
invasive infections between the emm1 (p £0.0001) and
emm18 (p £0.007) types and speA, and between the emm76
and st432 types and ssa (p £0.001).
Among non-invasive infections, there were signiﬁcant asso-
ciations between the emm3 type and speA (p £0.009), and
between the emm6 type and speC (p £0.02).
Discussion
This is the ﬁrst molecular epidemiological study of GAS iso-
lates causing both invasive and non-invasive infections in
Tunisia. Our results revealed 38 emm proﬁles that were
different from those reported from previous studies in
America, Asia and Europe [4,7,12,13].
Associations between emm types and clinical manifesta-
tions have been reported in several studies [4,14]. In the
present study, there was a signiﬁcant association between
emm1, emm76 and emm18 and invasive GAS infections. The
most prevalent type in invasive infections as reported world-
wide was emm1[4,14]. However, the prevalence of emm3 in
NF and STSS cases that has been described in the USA, Can-
ada and other countries [4,15] was not observed in the pres-
ent study. The two isolates causing STSS were emm76, and
the two causing NF were emm85 and emm67.
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FIG. 1. Results of T and emm typing of group A streptococcus iso-
lates. (a) Distribution of T patterns of the 61 typeable strains
accounting for 59% of the 103 Streptococcus pyogenes strains. (b) Dis-
tribution of the 20 most common emm types of 47 invasive and 55
non-invasive strains of S. pyogenes (accounting for 82% of the
strains). *emm types included in the 26-valent vaccine. *Others
include three invasive and ﬁve non-invasive strains of genotypes
emm2, emm33, emm43, emm59, emm75, emm89, emm92 and emm94
(one strain each). Other non-vaccine types include six invasive and
ﬁve non-invasive strains of genotypes emm17, emm26, emm48,
emm66, emm85, emm87, emm102, emm104, st1389 and st2661UK
(one strain each).
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Furthermore, emm118 and emm42, the most predominant
types in non-invasive cases in this study, have been rarely
reported before [12], and emm28, which in this study was
frequently identiﬁed in non-invasive isolates, was reported
with a high frequency among invasive infections, ﬁrst in Fin-
land and France, and more recently in other European coun-
tries [16,17].
The distribution of toxin gene proﬁles conﬁrmed that
speB encoding the streptococcal pyrogenic exotoxin B was
highly conserved [18], whereas speA, speC and ssa were
present at variable frequencies. The presence of speA was
positively correlated with invasive infections in our study,
which conﬁrmed that it is an important virulence factor in
invasive infection. However, other studies reported that
the prevalence of ssa was also high among invasive isolates
[7].
The presence of speC in 44% of isolates obtained from
the pharynx was in accordance with the ﬁndings of Jing et al.
[13], who found that speC and bacteriophage induction are
pharyngeal cell-dependent.
The presence of toxin genes with different proﬁles and
their relationship with emm types have been previously
noted [12]. All emm1 isolates carried speA in association or
not with speC (50% in our study), but never with ssa, as pre-
viously described [12]. They also shared the biotype 1, sero-
type T1 and susceptibility to antibiotics with the globally
disseminated clonal M1T1 strain. This clone is responsible
for cases of highly invasive human diseases and has peculiar
characteristics, such as three prophages, one of which carries
speA [19].
Consistent with the ﬁndings of a previous Tunisian study
[20], biotype 3 was the most prevalent biotype; this is differ-
ent from the situation in other countries, where biotype 1
has the highest prevalence [9].
T typing is a preliminary method that adds important
information, which is in agreement with data provided by
genotypic methods. The advantage of using both T typing
and molecular methods is that it facilitates comparisons
among GAS isolates from different countries and at different
times. Nevertheless, several factors can cause difﬁculties in
the interpretation of T typing results [21]. In this study, 41%
of the isolates were non-typeable, and most of these isolates
shared cross-reactions with several different sera. Of the
T patterns identiﬁed, T3/13/B3264, T1, T4 and T11 were the
most frequent, but the emm–T combinations differed from
those commonly reported in other countries, except for
emm1–T1 [21].
Susceptibility to bacitracin is one of the preliminary labo-
ratory tests used for presumptive differentiation of S. pyoge-
nes from other b-haemolytic streptococci; this property
appears to be an epidemiological marker of antibiotic multi-
resistance among emm28 isolates [16].
S. pyogenes is still uniformly susceptible to penicillin G,
which remains the drug of choice for treating streptococ-
cal infections. Erythromycin and other macrolides have
been recommended as alternative treatments for patients
who are allergic to penicillin. The rate of macrolide resis-
tance varies between different countries. It remains low
(5%) in the Tunis area, and even lower in Argentina <1%
[22]. In Europe, the rates of resistance over the last dec-
ade have ranged from 2% in the UK, to 10% in Sweden,
to 17% in Finland, and up to 47% in Italy [23]. All of the
erythromycin-resistant isolates in the present study
expressed the cMLSB phenotype, in contrast to what was
found in previous studies in European countries such as
Finland [24] and Italy [25], where the M phenotype was
predominant. The ﬁve erythromycin-resistant GAS isolates
belonged to the emm28, emm11 and emm12 types. The
emm28 erythromycin-resistant isolates showed high levels
of resistance to streptomycin and kanamycin, suggesting
their close relationship to the multiresistant European
clone [16]. Kim and Lee [26] reported that, in Korea,
most emm12 strains showed constitutive resistance,
whereas emm18 and emm75 strains showed the M pheno-
type. A high tetracycline resistance rate was observed
(71%), similar to that in Brazil, Iran, China and Denmark
[13,27–29]. This high resistance rate could be related to
the use of tetracycline in veterinary medicine [30].
In conclusion, this study provides the ﬁrst epidemiological
data on GAS in Tunisia that include emm sequence types. It
demonstrates that biotype 3, serotype T3/13/B3264 and
emm118 were the most frequent GAS types in Tunisia. Iso-
lates of the emm1 and emm18 types were associated with
the presence of speA and invasive infections. Such data will
be useful for further understanding the epidemiology of GAS
diseases, and for the development of an appropriate vaccine,
particularly in our country, where the incidence of rheumatic
fever remains high.
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